Normal view MARC view ISBD view

Gly101Val BCL2 Mutation: One Step Closer to Understanding Venetoclax Resistance in CLL.

Thangavadivel, Shanmugapriya

Gly101Val BCL2 Mutation: One Step Closer to Understanding Venetoclax Resistance in CLL. [electronic resource] - Cancer discovery 03 2019 - 320-322 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment

ISSN: 2159-8290

Standard No.: 10.1158/2159-8290.CD-19-0029 doi

Subjects--Topical Terms:
Antineoplastic Agents
Bridged Bicyclo Compounds, Heterocyclic
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Mutation
Patients
Proto-Oncogene Proteins c-bcl-2
Sulfonamides

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)